News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mirus Bio Corporation Releases for Sale TransIT(R)-2020


9/9/2009 8:37:00 AM

MADISON, Wis., Sept. 8 /PRNewswire/ -- From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.

Mirus has expanded its transfection expertise with the development of a high performance, animal-free, broad spectrum DNA transfection reagent which offers users:

Visit www.mirusbio.com for all your transfection needs including data, protocols, technical support or to place an order.

The Transfection Experts

For over a decade, Mirus pioneered scientific breakthroughs in non-viral gene delivery. These advancements established our products as industry leading transfection reagents. At Mirus, we continue to grow our expertise in nucleic acid delivery research and products to better serve you.

SOURCE Mirus Bio LLC

CONTACT: Laura Juckem, Ph.D. of Mirus Bio LLC, +1-608-238-4400, Fax,
+1-608-441-2849, laura.juckem@mirusbio.com

Web site: http://www.mirusbio.com/


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES